Live feed
Filing
SC 13D
SC 13D0001493152-24-035256·COSCIENS Biopharma Inc.
Schedule 13D ownership disclosure
Cosciens Biopharma Inc
Security class unavailable · CUSIP: 22112H101
Event date: 2024-08-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 221,570
- Percent of class
- 7.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-24-035256
- Form type
- SC 13D
- Filer
- COSCIENS Biopharma Inc.
- CIK
- CIK 1113423
- Filed
- Sep 06, 2024
- Reporting period
- Aug 29, 2024
- Description
- Schedule 13D beneficial ownership